Old Web
English
Sign In
Acemap
>
authorDetail
>
Kosuke Hamada
Kosuke Hamada
Osaka City University
Pathology
Medicine
Castration
Prostate cancer
Cancer research
4
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A retrospective study.
2019
Journal of Clinical Oncology
Kosuke Hamada
Taro Iguchi
Satoshi Tamada
Minoru Kato
Takeshi Yamasaki
Yuji Takeyama
Yasuomi Shimizu
Sayaka Yasuda
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (0)
Development of myeloid-derived suppressor cells (MDSC) targeted therapy for the treatment of cisplatin-resistant bladder cancer.
2019
Journal of Clinical Oncology
Yuji Takeyama
Minoru Kato
Yasuomi Shimizu
Kosuke Hamada
Taro Iguchi
Satoshi Tamada
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (0)
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: A retrospective study.
2019
International Journal of Clinical Oncology
Taro Iguchi
Satoshi Tamada
Minoru Kato
Sayaka Yasuda
Taiyo Otoshi
Kosuke Hamada
Takeshi Yamasaki
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (7)
The effect of androgen receptor splice variant 7 on the growth of castration-resistant prostate cancer and the efficacy of taxane chemotherapy.
2019
Journal of Clinical Oncology
Yasuomi Shimizu
Minoru Kato
Yuji Takeyama
Kosuke Hamada
Taro Iguchi
Satoshi Tamada
Tatsuya Nakatani
Show All
Source
Cite
Save
Citations (0)
1